DOI:
10.1055/s-00000129
Kardiologie up2date
LinksClose Window
References
Giugliano RP, Newby LK, Harrington RA. et al
The early glycoprotein IIb/IIIa inhibition in non-ST-segment elevation acute coronary syndrome (EARLY ACS) trial:a randomized placebo-controlled trial evaluating the clinical benefits of early front-loaded eptifibatide in the treatment of patients with non-ST-segment elevation acute coro(Paclitaxel-coated balloon catheter versus pacli [Paclitaxel-coated balloon catheter versus paclitaxel-coated stent for the treatment of coronary in-stent restenosis.
Am Heart J 2005; 149: 994-1002
We do not assume any responsibility for the contents of the web pages of other providers.